The first scientific studies on the hemp plant were conducted in the mid-20th century. Initially, the goal was to identify the chemical structure of its components. Later, research focused on the molecular targets of cannabinoids within our bodies, leading to the discovery of the endocannabinoid system (ECS)—a network consisting of cannabinoid receptors and the body’s own endocannabinoids.
The structural framework for many well-known medications originates from so-called "natural substances"—active ingredients derived from nature (such as penicillin, which comes from mold). The hemp plant, with its wealth of natural compounds, has long been—and continues to be—a subject of interest for the development of new medicines.
The endocannabinoid system and endogenous cannabinoids.
Most people are only familiar with the term "cannabinoid" in the context of compounds found in the hemp plant. It refers to a group of substances that exert various effects on our bodies when the hemp plant is consumed. Endocannabinoids, by contrast, are less well-known; they are not absorbed from the environment but are instead endogenous molecules that act upon the same receptors in our bodies as the better-known cannabinoids. The prefix "endo-" is derived from Greek, meaning "within" or "inside," and in this context, it signifies "endogenous" (originating from within the body).
Endocannabinoids: vital signaling molecules in our bodies.
Endocannabinoids are the body’s own signaling molecules that act on the same receptors as phytocannabinoids like THC and CBD. It is important to distinguish between these terms: endocannabinoids (produced naturally within the body), phytocannabinoids (found in the hemp plant), and synthetic cannabinoids (produced artificially). The receptors upon which all these cannabinoids act are known as cannabinoid receptors, the two best-known examples being the CB1 and CB2 receptors. It was first discovered that the endocannabinoid "anandamide"—much like THC—acts upon the CB1 receptor. Anandamide is a fatty acid that, at first glance, appears to have little structural resemblance to THC.
Subsequently, a whole range of other endocannabinoids were discovered, such as noladin ether and 2-arachidonoylglycerol (2-AG). All known endocannabinoids are synthesized within the body from the omega-6 fatty acid, arachidonic acid. New components of the endocannabinoid system—which comprises both the endocannabinoids themselves and their corresponding receptors—continue to be discovered today.
The CB1 Receptor
Endocannabinoids that act upon the CB1 receptor, such as anandamide, play an important role in brain development by promoting the interconnection of nerve cells. It has been found that the release of endocannabinoids occurs primarily during times of stress, at which point their interaction with the CB1 receptor produces an analgesic (pain-relieving) effect. CB1 receptor activity is also associated with a variety of other effects, including increased appetite, reduced anxiety, a protective effect following brain injury, and the alleviation of withdrawal symptoms. Following the discovery that the activation of the CB1 receptor stimulates appetite, a CB1 blocker—a substance that inhibits rather than activates the receptor—known as rimonabant was developed; it effectively counters hunger. It was used in the treatment of obesity to reduce feelings of hunger in patients.
The CB2 Receptor
The CB2 receptor is the second well-known type of cannabinoid receptor. It is primarily mentioned in relation to the phytocannabinoid cannabidiol (CBD), as it serves as a prominent target structure for this popular cannabinoid. In addition to the phytocannabinoid CBD, the endocannabinoid 2-arachidonoylglycerol also acts upon this cannabinoid receptor. In humans, the CB2 receptor is found in the central and peripheral nervous systems, the gastrointestinal tract, and various immune system cells. In many studies, the activity of the CB2 receptor within the immune system is described as anti-inflammatory and is the subject of intensive research.
The Human Endocannabinoid System
THC and CBD act upon the same receptors as the body’s own endocannabinoids. Endocannabinoids are produced within the body from omega-6 fatty acids. The most significant functions of the CB1 receptor include pain relief and the stimulation of appetite, while the primary function of the CB2 receptor is the inhibition of inflammatory processes. To better understand the effects of phytocannabinoids on the endocannabinoid system, it is essential to build tolerance and fully harness their potential.






